Autres langues Dr. Reddy's Laboratories Limited

Actions

DRREDDY

INE089A01031

Produits pharmaceutiques

Marché Fermé - Bombay S.E. 12:20:10 03/09/2026			Varia. 5j.	Varia. 1 janv.
1 155,00 ^INR	-0,52%		-1,70%	-9,13%

14:40	Aspen prévoit des ventes de Mounjaro en Afrique supérieures à 124 millions de dollars en 2027	RE
02/09	Les actions asiatiques cotées aux États-Unis sous forme d'American Depositary Receipts progressent lors de la séance de mercredi	MT

Autres langues

14:40	Aspen sees Mounjaro Africa sales above $124 million in 2027
02/09	Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
01/09	Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
31/08	Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading
25/08	Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
18/08	Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading
17/08	Dr Reddys Laboratories Receives Form 483 with Four Observations from USFDA After GMP Inspection At Formulations Manufacturing Facility
14/08	Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
14/08	Gland Pharma Names Dr. Reddy's Executive as CEO
13/08	Asian Equities Traded in the US as American Depositary Receipts Marginally Higher in Thursday Trading
13/08	Dr. Reddy's Laboratories Limited Announces Resignation of Deepak Sapra from Ceo, Api and Services and Senior Management Personnel, Effective November 12, 2026
12/08	Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
12/08	Indian shares subdued as higher crude prices weigh
11/08	Global drugmakers invest billions to boost US presence
11/08	Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
10/08	Asian Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
07/08	Novartis India Limited Terminates Distribution and Promotion Agreement with Dr. Reddy?S Laboratories Limited
06/08	Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
05/08	Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
04/08	Dr. Reddy?s Laboratories Ltd. Announces Launch Of Sugammadex Injection 200 Mg/2 Ml And 500 Mg/5 Ml Single-Dose Vials In The United States
04/08	Dr. Reddy's Laboratories Launches Sugammadex Injection Single-Dose Vials in US
04/08	Dr. Reddy's Launches Generic Sugammadex Injection in U.S.
04/08	Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States
03/08	Fresenius Kabi Announces FDA Approval of Rituximab Biosimilar Developed by Dr. Reddy's Laboratories for U.S. Market
03/08	Dr. Reddy's Laboratories Says US FDA Approves Rituximab Biosimilar for US Market